ArticlePharmaceuticals (Basel, Switzerland)2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.
Juliana Salazar, María J Arranz, Javier Martin-Broto, Massimo Serra, Emanuela Palmerini, Jeronimo Martínez-García, Antonio Juan-Ribelles, Maitane Andion, Javier Martinez-Trufero, Guiomar Gutiérrez and 8 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Juliana SalazarTranslational Medical Oncology Laboratory, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0002-3581-4499 María J ArranzResearch Laboratory Unit, Fundació Docència i Recerca Mútua Terrassa, 08221 Terrassa, Spain.ORCID 0000-0002-6757-9198 Javier Martin-BrotoMedical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain.ORCID 0000-0001-7350-6916 Massimo SerraOsteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.ORCID 0000-0003-0742-1177 Emanuela PalmeriniOsteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.ORCID 0000-0003-3406-6705 Jeronimo Martínez-GarcíaMedical Oncology Department, Hospital Universitario Virgen de la Arrixaca, 30120 El Palmar, Spain.ORCID 0000-0002-2295-5161 Antonio Juan-RibellesPediatric Oncology and Hematology Unit, Hospital Universitario y Politécnico La Fe de Valencia, 46026 Valencia, Spain.ORCID 0000-0002-2662-7632 Maitane AndionPediatric Hematology and Oncology Department, Hospital Niño Jesús, 28009 Madrid, Spain.
Javier Martinez-TruferoMedical Oncology Department, University Hospital Miguel Servet, 50009 Zaragoza, Spain.ORCID 0000-0002-0997-2573 Guiomar GutiérrezHospital Regional Universitario de Málaga, 29010 Málaga, Spain.
Aizpea Echebarria-BaronaPediatric Oncology Group, Pediatrics Department, Hospital Universitario Cruces, 48940 Barakaldo, Spain.
Maria A Vaz-SalgadoMedical Oncology Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Alexandra RegueiroMedical Oncology Department, Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.ORCID 0000-0003-3156-4784 Rosa AlvarezMedical Oncology Department, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0003-0935-8298 Claudia ValverdeMedical Oncology Department, Vall d'Hebrón Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebrón, 08035 Barcelona, Spain.
Pablo LunaMedical Oncology Department, Hospital Universitari Son Espases, 07120 Palma, Spain.
Pilar BlayMedical Oncology Department, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Ana SebioTranslational Medical Oncology Laboratory, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-3333-2370 Funding
Spanish Group of Sarcoma Research (GEIS) Translational research projects by young researchers 2017
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
osteosarcomapharmacogeneticspolymorphismVEGF
Identifiers
PMID41471344
PMCPMC12735774
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390